Steve Schwartz

Mr. Schwartz brings over 30 years of experience in corporate and business development from some of the nation’s leading health technology companies. He currently serves as Executive VP of Corporate Development at Transcarent. Prior to that Mr. Schwartz was senior vice president of Business and Corporate Development at Livongo that achieved Nasdaq’s largest digital health IPO, and then a year later helped lead the company’s $18.5 billion mergers with Teladoc.

Mr. Schwartz began his career as a sales and business development leader for LabCorp, where for over a decade helped build the clinical lab company into an industry-leading multi-billion-dollar success. For the next 12 years, he led corporate business development for Allscripts, where he was responsible for building the company’s massive partner ecosystem and managing strategic acquisitions while the electronic health record company grew by more than ten-fold.